SEEL

Seelos Therapeutics (SEEL)

Seelos Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:SEEL

<< 前へ 1 2 3 4 5 6 7 8 9 10 11 12 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2020/05/16	06 : 20	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SEEL	Seelos Therapeutics Inc
2020/05/16	06 : 00	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:SEEL	Seelos Therapeutics Inc
2020/05/15	23 : 32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SEEL	Seelos Therapeutics Inc
2020/05/15	23 : 30	GlobeNewswire Inc.	Seelos Therapeutics Announces Appointment of Judith Dunn to the Board of Directors	NASDAQ:SEEL	Seelos Therapeutics Inc
2020/05/15	20 : 30	GlobeNewswire Inc.	Seelos Therapeutics Receives Rare Pediatric Disease Designation for SLS-005 (Trehalose) in Sanfilippo Syndrome	NASDAQ:SEEL	Seelos Therapeutics Inc
2020/05/12	21 : 01	GlobeNewswire Inc.	Seelos Therapeutics to Participate in the Jefferies Virtual Healthcare Conference	NASDAQ:SEEL	Seelos Therapeutics Inc
2020/05/08	05 : 36	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:SEEL	Seelos Therapeutics Inc
2020/05/05	05 : 02	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:SEEL	Seelos Therapeutics Inc
2020/05/04	21 : 01	GlobeNewswire Inc.	Seelos Therapeutics Receives Notice of Allowance for an Additional US Patent for Trehalose (SLS-005)	NASDAQ:SEEL	Seelos Therapeutics Inc
2020/05/01	02 : 31	GlobeNewswire Inc.	Seelos Therapeutics Receives Orphan Drug Designation for SLS-005 (Trehalose) in Sanfilippo Syndrome	NASDAQ:SEEL	Seelos Therapeutics Inc
2020/04/25	05 : 16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SEEL	Seelos Therapeutics Inc
2020/04/18	05 : 16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SEEL	Seelos Therapeutics Inc
2020/04/14	05 : 36	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:SEEL	Seelos Therapeutics Inc
2020/04/08	22 : 01	GlobeNewswire Inc.	Seelos Therapeutics Provides Q1 2020 Business Update and Pipeline Developments	NASDAQ:SEEL	Seelos Therapeutics Inc
2020/04/02	06 : 22	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:SEEL	Seelos Therapeutics Inc
2020/03/31	05 : 17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SEEL	Seelos Therapeutics Inc
2020/03/24	21 : 01	GlobeNewswire Inc.	Seelos Therapeutics Announces Additional Interim Data from Phase I Studies of Intranasal Racemic Ketamine (SLS-002)	NASDAQ:SEEL	Seelos Therapeutics Inc
2020/03/18	06 : 21	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:SEEL	Seelos Therapeutics Inc
2020/03/17	05 : 31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SEEL	Seelos Therapeutics Inc
2020/03/17	05 : 30	GlobeNewswire Inc.	Seelos Therapeutics Announces Closing of Public Offering of Common Stock	NASDAQ:SEEL	Seelos Therapeutics Inc
2020/03/13	06 : 28	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:SEEL	Seelos Therapeutics Inc
2020/03/13	06 : 25	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SEEL	Seelos Therapeutics Inc
2020/03/12	09 : 30	GlobeNewswire Inc.	Seelos Therapeutics Announces Pricing of $4.5 Million Public Offering of Common Stock	NASDAQ:SEEL	Seelos Therapeutics Inc
2020/03/12	05 : 19	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:SEEL	Seelos Therapeutics Inc
2020/03/12	05 : 15	GlobeNewswire Inc.	Seelos Therapeutics Announces Proposed Public Offering of Common Stock	NASDAQ:SEEL	Seelos Therapeutics Inc
2020/03/11	21 : 01	GlobeNewswire Inc.	Seelos Therapeutics Announces European Medicines Agency Guidance to Design an Open-Label Pivotal Study for SLS-005 in Sanfili...	NASDAQ:SEEL	Seelos Therapeutics Inc
2020/03/06	23 : 41	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:SEEL	Seelos Therapeutics Inc
2020/03/06	22 : 01	GlobeNewswire Inc.	Seelos Therapeutics Receives Notice of Allowance for Composition of Matter Patent for SLS-007	NASDAQ:SEEL	Seelos Therapeutics Inc
2020/02/26	22 : 01	GlobeNewswire Inc.	Seelos Therapeutics Announces Additional Interim Data from Phase I Studies of Intranasal Racemic Ketamine (SLS-002)	NASDAQ:SEEL	Seelos Therapeutics Inc
2020/02/19	22 : 02	GlobeNewswire Inc.	Seelos Therapeutics to Participate in Two Upcoming Investor Conferences in March	NASDAQ:SEEL	Seelos Therapeutics Inc